Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical study.
Chlorpromazine (CHP) in a concentration of 8.3 microgram per ml medium inhibited attachment and multiplication of CEC and of various cell lines. The same CHP concentration applied to grown CEC monolayers inhibited the growth of TBEV but not the growth of HHV 1, while interferon was slightly stimulated. The clinical course of fatal subcutaneous TBEV infection in mice was not affected by daily CHP treatment while brain and serum interferon were stimulated. Antibody formation in TBEV infected or HHV 1 immunized mice was not affected significantly by CHP application. The following data were obtained in a longitudinal study on 28 hospitalized schizophrenic patients: 89 percent of them revealed at least some serological findings which indicate an actual HHV 1 infectious process-elevated NAB titers, high ratio between complement requiring and complement not requiring NAB titers. A low interferon activity was observed in serum and cerebrospinal fluid of 93 percent and 14 percent patients, respectively. No regular correlation between HHV 1-NAB-both complement requiring and complement not requiring-and of interferon on one side and between hospitalization. CHP treatment and electroconvulsive therapy on the other side has been observed.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation / Q000187:drug effects; D002460:Cell Line; D002746:Chlorpromazine / Q000627:therapeutic use*; D004565:Electroconvulsive Therapy; D006801:Humans; D007372:Interferons; D007739:L Cells; D051379:Mice; D012559:Schizophrenia / Q000628:therapy*; D018139:Simplexvirus; D014779:Virus Replication / Q000187:drug effects
D000906:Antibodies; D007372:Interferons; D002746:Chlorpromazine